Trevi Therapeutics, Inc. (TRVI) Financials

TRVI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 89.4 million 6.9 million
2023-09-30 95.9 million 6.3 million
2023-06-30 101.0 million 5.9 million
2023-03-31 116.2 million 14.5 million

TRVI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.4 million 534000
2023-09-30 -7.3 million 530000
2023-06-30 -9.9 million 605000
2023-03-31 -8.3 million 578000

TRVI Net Income

No data available :(

TRVI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 1.3 million
2023-09-30 88.9 million - 1.4 million
2023-06-30 94.2 million - 1.5 million
2023-03-31 11.7 million - 1.5 million

TRVI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 68.3 million
2023-09-30 99.3 million
2023-06-30 98.7 million
2023-03-31 98.6 million

TRVI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 22000 6.5 million 2.4 million -
2023-09-30 18000 6.3 million 2.7 million -
2023-06-30 40000 5.8 million 2.5 million -
2023-03-31 57000 5.0 million 2.6 million -

TRVI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - 35000
2023-06-30 - 34000
2023-03-31 - 19000

TRVI

Price: $3.02

52 week price:
0.97
4.00

Earnings Per Share: -0.29 USD

P/E Ratio: -7.45

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 28000

Market Capitalization: 201.4 million

Links: